Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 68.2 TWD 0.89% Market Closed
Market Cap: 11.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Tanvex BioPharma Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tanvex BioPharma Inc
Income from Continuing Operations Peer Comparison

Comparables:
688235
6550

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Tanvex BioPharma Inc
TWSE:6541
Income from Continuing Operations
-NT$1.8B
CAGR 3-Years
-2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Income from Continuing Operations
-ÂĄ6.7B
CAGR 3-Years
16%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Polaris Group
TWSE:6550
Income from Continuing Operations
-NT$1.6B
CAGR 3-Years
-34%
CAGR 5-Years
-9%
CAGR 10-Years
N/A

See Also

What is Tanvex BioPharma Inc's Income from Continuing Operations?
Income from Continuing Operations
-1.8B TWD

Based on the financial report for Jun 30, 2024, Tanvex BioPharma Inc's Income from Continuing Operations amounts to -1.8B TWD.

What is Tanvex BioPharma Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
2%

Over the last year, the Income from Continuing Operations growth was 9%. The average annual Income from Continuing Operations growth rates for Tanvex BioPharma Inc have been -2% over the past three years , 2% over the past five years .

Back to Top